Literature DB >> 24052421

SUMO: a (oxidative) stressed protein.

Marco Feligioni1, Robert Nisticò.   

Abstract

Redox species are produced during the physiological cellular metabolism of a normal tissue. In turn, their presence is also attributed to pathological conditions including neurodegenerative diseases. Many are the molecular changes that occur during the unbalance of the redox homeostasis. Interestingly, posttranslational protein modifications (PTMs) play a remarkable role. In fact, several target proteins are modified in their activation, localization, aggregation, and expression after the cellular stress. Among PTMs, protein SUMOylation represents a very important molecular modification pathway during "oxidative stress". It has been reported that this ubiquitin-like modification is a fine sensor for redox species. Indeed, SUMOylation pathway efficiency is affected by the exposure to oxidative species in a different manner depending on the concentration and time of application. Thus, we here report updated evidence that states the role of SUMOylation in several pathological conditions, and we also outline the key involvement of c-Jun N-terminal kinase and small ubiquitin modifier pathway cross talk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24052421     DOI: 10.1007/s12017-013-8266-6

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  111 in total

1.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation.

Authors:  A Behrens; M Sibilia; E F Wagner
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

Review 2.  Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins.

Authors:  Sue Goo Rhee; Sang Won Kang; Woojin Jeong; Tong-Shin Chang; Kap-Seok Yang; Hyun Ae Woo
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

Review 3.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

Review 4.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

5.  SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis.

Authors:  X Li; Y Luo; L Yu; Y Lin; D Luo; H Zhang; Y He; Y-O Kim; Y Kim; S Tang; W Min
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

6.  Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation.

Authors:  Zheng Xu; Levina Suk Mi Lam; Lok Hei Lam; So Fun Chau; Tzi Bun Ng; Shannon Wing Ngor Au
Journal:  FASEB J       Date:  2007-08-17       Impact factor: 5.191

7.  Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR.

Authors:  Luca Rosario La Rosa; Carmela Matrone; Caterina Ferraina; Maria Beatrice Panico; Silvia Piccirilli; Maria Grazia Di Certo; Georgios Strimpakos; Nicola Biagio Mercuri; Pietro Calissano; Marcello D'Amelio; Robert Nisticò
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 8.  Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress.

Authors:  Laia Trigueros-Motos; Jose M Gonzalez; Jose Rivera; Vicente Andres
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

9.  Regulation of protein tyrosine phosphatase 1B by sumoylation.

Authors:  Shrikrishna Dadke; Sophie Cotteret; Shu-Chin Yip; Zahara M Jaffer; Fawaz Haj; Alexey Ivanov; Frank Rauscher; Ke Shuai; Tony Ng; Benjamin G Neel; Jonathan Chernoff
Journal:  Nat Cell Biol       Date:  2006-12-10       Impact factor: 28.824

10.  Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells.

Authors:  Joaquín Navascués; Rocio Bengoechea; Olga Tapia; José P Vaqué; Miguel Lafarga; Maria T Berciano
Journal:  Chromosoma       Date:  2007-05-26       Impact factor: 2.919

View more
  24 in total

1.  Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Authors:  Anja Büchner; Petranka Krumova; Sundar Ganesan; Mathias Bähr; Katrin Eckermann; Jochen H Weishaupt
Journal:  Neuromolecular Med       Date:  2014-11-13       Impact factor: 3.843

2.  HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.

Authors:  Xiao Han; Xin-Ling Wang; Qin Li; Xiao-Xuan Dong; Jin-Song Zhang; Qi-Chang Yan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-16       Impact factor: 3.117

3.  SUMOylation in neuroplasticity and neurological disorders.

Authors:  Marco Feligioni; Mark P Mattson; Robert Nisticò
Journal:  Neuromolecular Med       Date:  2013-12       Impact factor: 3.843

4.  Posttranslational modifications in proteins: resources, tools and prediction methods.

Authors:  Shahin Ramazi; Javad Zahiri
Journal:  Database (Oxford)       Date:  2021-04-07       Impact factor: 3.451

Review 5.  Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease.

Authors:  Serena Marcelli; Elena Ficulle; Filomena Iannuzzi; Enikö Kövari; Robert Nisticò; Marco Feligioni
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

6.  Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.

Authors:  Yu-Lin Sun; Jian-Qiang Cai; Fang Liu; Xin-Yu Bi; Lan-Ping Zhou; Xiao-Hang Zhao
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

7.  SUMOylation occurs in acute kidney injury and plays a cytoprotective role.

Authors:  Chunyuan Guo; Qingqing Wei; Yunchao Su; Zheng Dong
Journal:  Biochim Biophys Acta       Date:  2014-12-19

Review 8.  Oxidative Stress and Neurobiology of Demyelination.

Authors:  Srdjan Ljubisavljevic
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

9.  [Human RhoA is modified by SUMO2/3].

Authors:  Yingcong Wan; Chunyan Li; Jiayao She; Jingya Wang; Ming Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30

10.  Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology.

Authors:  David J Hughes; Christian Tiede; Natalie Penswick; Anna Ah-San Tang; Chi H Trinh; Upasana Mandal; Katarzyna Z Zajac; Thembaninskosi Gaule; Gareth Howell; Thomas A Edwards; Jianxin Duan; Eric Feyfant; Michael J McPherson; Darren C Tomlinson; Adrian Whitehouse
Journal:  Sci Signal       Date:  2017-11-14       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.